Tags
- AAIPharma Services
- AAPS 2011
- AAPS2011
- AARP
- Abacavir
- Abbas Hussein
- Abbott Laboratories
- Abilify
- Abraxane
- Abraxis
- academic research
- Acambis
- Acclarent
- Accolate
- Accord
- Accupril
- Accutane
- acetaminophen
- Acino
- Acomplia
- Acorda Therapeutics
- Actavis
- Actelion
- Actemra
- Actera
- Acthar
- ActHIB
- Actimmune
- Activase
- Active Biotech
- Active Ingredients
- Actos
- Acusphere
- Aczone
- Adasuve
- Adcentris
- Adcirca
- Adcock Ingram
- Adderall
- addiction
- ADHD
- ADHD patch
- adjuvants
- Adolor
- Advair
- Advaxis
- Adverse events
- advertising spending
- Advisory panels
- Advocacy Groups
- Aetna
- Afexa Life Sciences
- Afinitor
- Africa
- Agilent Technologies
- AIDS
- Ajit Patel
- Akorn
- Alabama
- Alan Hippe
- Alan Johnson
- Alan Schatzberg
- Albemarle
- Alcoholism
- Alcon
- Alex Denner
- Alex Gorsky
- Alexion Pharmaceuticals
- Alexza Pharmaceuticals
- Alimta
- Alkaloida
- Alkermes
- Allegra
- Allergan
- Alli
- Allopurinol
- Allos Therapeutics
- Almac
- Almirall
- Alpharma
- Altace
- Alternative Technology Pharma
- Altus Pharmaceuticals
- Alvogen Group
- Alzheimer's
- Alzheimer's Society
- Amag
- Ambien
- American College of Physicians
- American Diabetes Association
- American Journal of Obstetrics and Gynecology
- American Medical Association
- American Medical Student Association
- American Pharmacists Association
- American Red Cross
- American Regent
- AmerisourceBergen
- Amgen
- amlodipine besylate
- Amneal
- Amoun
- Amphastar
- Amplify
- Ampyra
- AMRI
- AMS
- Amy Klobuchar
- Amy Schulman
- Amylin
- Amylin Pharmaceuticals
- Amyris
- analysts
- Anascorp
- Andreas Fibig
- Andrew Bodnar
- Andrew Lansley
- Andrew von Eschenbach
- Andrew Wakefield
- Andrew Witty
- Android
- Anemia
- Anemia drugs
- Angiomax
- Angioplasty
- Angiotech
- Angus Russell
- Anika Therapeutics
- animal drugs
- Animal health
- animal rights activists
- Animas
- Ann Arbor
- Annals of Internal Medicine
- Anomatic
- Antara
- Anthera
- antibiotic
- antidepressant
- antipsychotics
- antitrust
- anxiety
- API
- apixaban
- Apollo Hospital Group
- Apotex
- APP Pharmaceuticals
- Apple
- Aptuit
- Aranesp
- ARBs
- ARCA
- Arcalyst
- Arcapta
- Argentina
- Ariad
- Aricept
- Arimidex
- Arixtra
- Arlen Specter
- Arrow Group
- arsalan arif
- Art Levinson
- Artes Medical
- Arthritis
- Arthur Higgins
- Arthur Levinson
- Arzerra
- Ascent Pharmahealth
- ASCO
- Asia
- Aspen Pharmacare
- AspenBio Pharma
- asset sale
- Astellas Pharma
- asthma
- Astra Tech
- AstraZeneca
- AstraZeneca - Top 10 pharma layoffs of 2011
- athletes
- ATMI
- atrial fibrillation
- Atripla
- Atrovent
- atypical antipsychotics
- Augmentin
- Aurobindo Pharma
- austerity measures
- Australia
- Australian Pharmaceutical Industries
- authorized generics
- autism
- Avalide
- Avandia
- Avanir
- Avastin
- Aventis Pharmaceuticals
- Avian Flu
- Avodart
- Avonex
- AVOS Life Sciences
- Avrio
- Axanum
- Axios Mobile Assets
- Axway
- Azasite
- AZD3480
- Azilect
- Azmacort
- Azor
- B. Braun
- Bain Capital
- Banyu Pharmaceutical
- bapineuzumab
- Barack Obama
- Barr Pharmaceuticals
- Bart Stupak
- Bausch & Lomb
- Baxter
- Baycol
- Bayer
- Bayer - Top 10 pharma layoffs of 2011
- Bedford Laboratories
- BellHawk Systems
- Ben Venue Laboratories
- Bend Research
- BeneLein Technologies
- Benicar
- Benlysta
- Bentley Pharmaceutical
- Bergamo
- Bernard Poussot
- Betaferon
- Betaseron
- Beth Martino
- Bev Lybrand
- Bextra
- Biaxin
- Big Pharma
- Bilim Ilac
- Bill And Melinda Gates
- Bill Clinton
- Bill Weldon
- Bill Wells
- Billy Tauzin
- bimatoprost
- Bimeda Groups
- binge eating
- Binnopharm
- BIO
- Biocon
- BioCritica
- BioDelivery Sciences
- Biofarma
- Biogen Idec
- Biological E
- biologics
- BioMarin
- biomarkers
- Biomet
- Bionovo
- Biopharm America
- biopharma industry
- biosimilars
- Biosite
- Biota
- Biotech analyst
- Biotech company news
- biotech IP
- biotech jobs
- Biotest Pharmaceuticals
- Biotin
- Biovail
- Biovest International
- birth control
- Bisphosphonates
- black box
- Blacksmith Brands
- Blackstone Group
- blood sugar
- Bob Essner
- Bob Rappaport
- Boehringer Ingelheim
- Bond Issue
- Boniva
- Bonus
- Bormioli Rocco
- Boston Scientific
- Botox
- Bracco
- Bradley Pharma
- brain drain
- Brand Name Drugs
- Brazil
- Breast Cancer
- Brent Saunders
- Brian Markison
- Bridion
- Brilinta
- Brilique
- Bristol-Myers Squibb
- Bristolmyers Squibb
- Brown University
- Bruce Boise
- Busulfex
- Bydureon
- Byetta
- Bystolic
- C&O Pharmaceutical
- Cadence
- Cadila Healthcare
- Caduet
- Calestous Juma
- California
- campaign contributions
- Campath
- Canada
- cancer
- cancer drugs
- cancer vaccine
- Candela
- Capsugel
- Caraco
- Cardene
- Cardinal Health
- cardiovascular market
- cardiovascular risks
- cargo theft
- Carl Icahn
- Catalent Pharma
- CDC
- CDER
- Ceftobiprole
- Celebrex
- Celera
- Celexa
- Celgene
- CellCept
- Celsus
- Celvapan
- Center for Health Transformation
- Center for Healthcare Supply Chain Research
- Centocor
- Cephalon
- Cerezyme
- Cervarix
- cervical cancer
- CETP inhibitors
- CFO
- Chantix
- Charles Grassley
- Charles Nemeroff
- Charles River
- Chattem
- Chelsea Therapeutics
- Chiesi
- Children
- Children's Medication Algorithm Project
- Chile
- China
- China Aoxing
- China SFDA
- Chiron
- CHMP
- cholesterol
- cholesterol drug
- Chris Gleeson
- Chris Viehbacher
- Christine Poon
- Christopher Bowe
- chronic disease
- Chronic Obstructive Pulmonary Disease
- Cialis
- Cimzia
- Cipla
- Cipla Medpro South Africa
- Cipralex
- Cipro
- ciprofloxacin
- citizen's petition
- Clarinex
- Claris
- Claritin
- Clarus Ventures
- class action
- Cleveland BioLabs
- Cleveland Clinic
- Climara
- Clinical Data
- Clinical Trial
- clinical trial ethics
- Clinical Trial Results
- Clolar
- clozapine
- Clozaril
- CME
- CMO
- CMR International
- co-pay
- Co-pay coupons
- colchicine
- Colcrys
- cold medicine
- Colon Cancer
- Colorado
- Colorectal Cancer
- CoLucid
- Combivent
- comeback
- companion diagnostics
- comparative effectiveness
- comparison
- Compensation Package
- Complera
- Compulsory licensing
- Comtan
- Concerta
- Conflict of interest
- Congress
- Connecticut
- consent decree
- consumer drugs
- Consumer Health
- Conte v. Wyeth
- Contraceptive
- Contract Manufacturer
- contract manufacturing
- Controversy
- COO
- Copaxone
- COPD
- Cordaptive
- Cordis
- Coreg
- Cornerstone Therapeutics
- Cosmeceuticals
- cosmetic pharmaceuticals
- cough medicine
- Counterfeit drugs
- Covance
- Covidien
- Cox 2
- Cozaar/Hyzaar
- Creabilis
- credit rating
- Credit Suisse
- Creon
- Crestor
- CRO
- Croatia
- Crohn's disease
- Crucell
- CryoPort
- CSL
- Cubicin
- Cubist
- Cumberland Pharmaceuticals
- Cuong Viet Do
- CV Therapeutics
- CVS
- cyclic lipopeptides
- Cycloset
- Cymbalta
- Cypher
- Cypress Bioscience
- cystic fibrosis
- Cytogen
- Czech Republic
- Dabur Pharma
- Daiichi Sankyo
- Dainippon
- Dalbavancin
- Dalton Pharma Services
- Daniel Bradbury
- Daniel Carpenter
- Daniel Nevrivy
- Daniel Schultz
- Daniel Troy
- Daniel Vasella
- darapladib
- Darrell Dotson
- Darrell Issa
- Darvon
- Dasen
- Dasgip
- DASware
- data-mining
- database
- Datatrak
- Datex
- Dave Gershon
- David Brennan
- David Dorsey
- David Kessler
- David Pyott
- David Shedlarz
- David Simmons
- David Stout
- David Vitter
- Daxas
- Daytrana
- DDN
- DEA
- Dean Mitchell
- Dear Doctor
- death penalty
- Debbie Stabenow
- Deborah Autor
- Debts
- defibrillator
- Deirdre Connelly
- Delaware
- Dementia
- Democrats
- dendreon
- Denise Torres
- Denosumab
- Depakote
- Department of Justice
- Department of Labor
- Depomed
- depression
- dermatology
- Dermik
- Detrol
- Deval Patrick
- developing nations
- dextromethorphan
- Dey Pharma
- DHL
- Diabetes
- Diabetes Drug
- Diagnostic and Statistical Manual of Mental Disorders
- diagostic tests
- Dialysis
- Diana Levine
- Dick Armey
- Diet Pills
- Dificid
- digital marketing
- Dilantin
- Diovan
- Direvo Biotech
- Disclosure
- discrimination
- Diversification
- diversify
- Diversion
- diversity
- DLA Piper
- doctor bribery
- doctors
- Don Therasse
- Donald Light
- Dong-A Pharmaceuticals
- doping
- Doribax
- Doryx
- Doxil
- Dr. Charles Eden
- Dr. Reddy's Laboratories
- drug abuse
- drug access
- drug adherence
- Drug advertising
- Drug coated stents
- Drug combo
- drug costs
- drug data
- drug development
- Drug Discovery
- drug distribution
- drug efficacy
- Drug Labels
- Drug launches
- Drug Marketing
- drug packaging
- drug prices
- drug rebates
- drug recall
- drug safety
- drug samples
- drug shortage
- drug spending
- drug studies
- drug theft
- drug-coated stents
- Drugmakers
- DSM
- DTC advertising
- Duragesic
- Durect
- Dyax
- Dysport
- e-prescribing
- Eastbourne Capital Management
- eBay
- Ebewe Pharma
- Economic development
- Edolphus Towns
- edronax
- Edwards Lifesciences
- effectiveness
- Effexor XR
- efficiency
- Effient
- Egypt
- Eisai
- Eisai - Top 10 pharma layoffs of 2011
- Elan
- Elder Pharmaceuticals
- Election 2008
- Eli Lilly
- Elidel
- Eliquis
- Elite Pharmaceuticals
- elotuzumab
- Eloxatin
- Elpen
- Embeda
- EMD Millipore
- EMEA
- EMEA approval
- EMEA inspection
- EMEA recommendation
- EMEA regulation
- emerging pharmaceutical markets
- Emory University
- Emtriva
- Enbrel
- Endo
- ENHANCE trial
- Enrico Veltri
- Enrique Conterno
- Entereg
- Eon Labs
- Epilepsy
- Epogen
- Eprex
- Equasym
- Erbitux
- erectile dysfunction
- Eric Winer
- Ethertronics
- Ethicon
- Eugene Melnyk
- Europe
- European Commission
- European Medicines Agency
- European Society of Cardiology
- European Union
- evergreening
- Evista
- Evolence
- executive prosecutions
- exenatide
- EXP Pharmaceutical Services
- Express Scripts
- Extavia
- Exubera
- eye treatments
- Eylea
- F. Michael Bell
- Fabrazyme
- Faes Farma
- Fairfield Group
- False Claims Act
- Fampyra
- Famvir
- Fanapt
- Fareva
- Faslodex
- FBI
- FCPA
- FDA
- FDA approvable letter
- FDA approval
- FDA approval process
- FDA fast track
- FDA funding
- FDA inspection
- FDA investigation
- FDA news
- FDA officials
- FDA recalls
- FDA recommendation
- FDA regulation
- FDA response letter
- FDA review
- FDA update
- FDA warning
- federal court
- Femara
- fentanyl
- Fentora
- Ferrosan
- Fibromyalgia
- Fierce 15
- financial reports
- Finland
- Firazyr
- Flemming Lindeløv
- Flomax
- Flonase
- Florida
- Flovent
- Flu Vaccine
- FluMist
- fluoroquinolones
- Fluzone
- Focalin
- follicular lymphoma
- Folotyn
- Foradil
- Forces Against Huntingdon Life Science
- Forest Laboratories
- Form 483
- Formatech
- Forteo
- Fosamax
- France
- Frank Baldino
- Frank D'Amelio
- Frank Torti
- Franz Humer
- Fred Baron
- Fred Hassan
- Frederick Goodwin
- Frederick Schiff
- FreedomWorks
- Fresenius
- FTC
- Fujifilm
- funding
- gabapentin
- Galderma
- galvus
- gambling
- GAO
- Gardasil
- Gary Buehler
- Gates Foundation
- GE Healthcare
- Gedeon Richter
- Gemzar
- Gen-Probe
- Gene Logic
- Genentech
- generic blocking
- generic competition
- Generic drugs
- Generic Initiative for Value and Efficiency
- generic injectables
- Generic Pharmaceutical Association
- generic switching
- Generics
- genetech
- Genetic profile
- Genetic screening
- Genmab
- Genzyme
- Geodon
- George Lorch
- George Soros
- Georgia
- Gerard Le Fur
- Germany
- Gestiva
- ghostwriting
- Gilead Sciences
- Gilenya
- Girindus
- GlaxoSmithKline
- Gleevec
- Glenmark
- Glivec
- GMP
- Goldman Sachs
- Goldshield Group
- Gordon Brown
- Goverment Accountability Office
- government shutdown
- GPhA
- Gralise
- Greece
- Greenstone
- Gruenenthal
- Grunenthal
- GSK
- Guangdong Techpool Bio-Pharma
- Guidant
- Guido Rasi
- H. Lundbeck
- H1N1
- H5n1 Vaccine
- hacking
- Halaven
- Halozyme Therapeutics
- Hana Biosciences
- Hank McKinnell
- Hanston
- Hanwha Chemical
- Harald zur Hausen
- Harbin
- Harold Sox
- Harvard
- Hawaii Biotech
- HDL
- Health Canada
- health insurance
- Health Problems
- HealthCare Institute of New Jersey
- healthcare reform
- HealthSport
- heart disease
- heartburn
- Helvepharm
- Hemo-Stream
- Hemosense
- Henri Termeer
- Henry Ford Health System
- Henry Waxman
- heparin
- Hepatitis B
- Hepatitis C
- Herb Kohl
- Herceptin
- Hexal
- Hib vaccine
- high blood pressure
- Hikma
- Hill Dermaceuticals
- Hill Labs
- Hillary Clinton
- HIV
- HIV prevention
- Hizentra
- Hodgkin's lymphoma
- Hollis-Eden
- Hollywood
- Hong Kong
- Horizant
- Hormonal Contraceptives
- hormone replacement therapy
- Hospira
- hostile takeover
- Hovione
- Howard A. Heit
- Howard Solomon
- HPV
- Human Genome Sciences
- Humana
- Humira
- Hungary
- Huntingdon Life Sciences
- Huntington's disease
- Hycamtin
- Hypermarcas
- hypertension
- I'Rom Pharmaceutical
- Ian Read
- Ib Sonderby
- iBio
- IBM
- Iceland
- Idaho
- identity theft
- IDT Biologika
- IFPMA
- Ilaris
- Illumina
- imaging drugs
- IMC-11F8
- ImClone
- Impax Laboratories
- import alert
- imports
- IMS
- IMS Health
- INC Research
- Incivek
- incontinence
- Indevus
- India
- Indocin
- Indoco Remedies
- Indonesia
- Industry Voices
- influence
- influentials
- influenza
- Infosys
- innovation
- iNova
- insider trading
- inspection
- Inspire Pharmaceuticals
- Institute of Medicine
- insulin
- INSYS Therapeutics
- Intelleflex
- Intellipharmaceutics
- Intercell
- InterMune
- Interpharm
- Interphex
- Intervet
- Intuniv
- Invega
- inVentiv Health
- Inverness Medical Innovations
- Investigations
- Invirase
- Iomai
- IP Rules
- iPad
- iPill
- Ipratropium
- ipratropium bromide
- Ipsen Pharmaceuticals
- Ireland
- Iressa
- Iroko
- IRS
- ischemic stroke
- Isentress
- Isis Pharmaceuticals
- ISPE
- Israel
- ISTA Pharmaceuticals
- Italy
- Ixempra
- J Craig Venter
- Jack Harris
- Jack Schuler
- Jack Tsao
- Jacobs Engineering
- JAMA
- James Cornelius
- James Mullen
- James Self
- James Stein
- Jane Henney
- Janet Woodcock
- Janet Woodcock. AAPS 2011
- Janssen Biotech
- Janssen Therapeutics
- Janumet
- Januvia
- Japan
- Jazz Pharmaceuticals
- Jean-Luc Bélingard
- Jean-Luc Belingard
- Jean-Marc Huet
- Jean-Pierre Garnier
- Jeff Bingaman
- Jeffrey Bostic
- Jeffrey Kindler
- Jeffrey Leiden
- Jeffrey Wang
- Jen Stotka
- Jeremy Levin
- Jerome Contamine
- Jerome Kassirer
- Jerrold Nadler
- Jevtana
- JHP
- Jiangsu Walvax Biotech
- Jim Connolly
- Jim Cornelius
- Jim Tobin
- Jiri Michal
- Joe Barton
- Joe Jimenez
- John Boehner
- John Castellani
- John Celentano
- John Dingell
- John Johnson
- John Kasteltein
- John Lechleiter
- John Martin
- John McCain
- John Taylor
- Johns Hopkins Medical School
- Johnson & Johnson
- Johnson & Johnson - Top 10 pharma layoffs of 2011
- Jonah Shacknai
- Jonathan Symonds
- Joseph Biederman
- Joseph Cook
- Joseph Ross
- Joshua Sharfstein
- JPMorgan
- Judge William Young
- Juergen Schwiezer
- Julie Gerberding
- JUPITER study
- Justice Department
- Juvaderm
- Juvisync
- Kaiser Permanente
- Kaletra
- Kalydeco
- Kansas
- Karen Wagner
- Karin Bitar
- Kathleen Sebelius
- Kelly Martin
- Ken Banta
- Kenalog
- Kenneth Frazier
- Keppra
- Ketamine
- Kevin Sharer
- kickbacks
- kidney cancer
- King Pharmaceuticals
- KKR
- Kombiglyze
- Korea
- KPMG
- KRAS gene
- Kroger
- Krystexxa
- KV Pharmaceuticals
- Kyowa Hakko Kirin
- Labcoat Limited
- LabCorp
- labeling
- Labopharm
- Laboratorio Teuto Brasileiro
- Laboratorios Kendrick
- Laboratorios Phoenix
- Labtec
- Lamberto Andreotti
- Lamictal
- Lamisil
- Lannett
- Lantus
- laquinimod
- Lars Bildman
- Lars Sorensen
- Latin America
- Latisse
- Latuda
- Laureate
- Lauren Stevens
- lawsuit
- LDL
- legislation
- Lemtrada
- Leo Pharma
- leucovorin
- Leukemia
- Levaquin
- Levitra
- Lexapro
- Lexicon Pharmaceuticals
- Lexiva
- licensing deals
- Life Pharma
- Life Technologies
- LifeConEx
- Lilly
- Line Extensions
- Lipitor
- Livalo
- Lobbying
- Lobbyists
- Lonza
- Lotus
- Louisiana
- Lovaza
- lovenox
- Lucentis
- Lufthansa Cargo
- Lumizyme
- Lundbeck
- Lunesta
- lung cancer
- Lupin
- Lyrica
- MabThera
- Macular Degeneration
- Maggie McGlynn
- major market trends
- Makena
- malaria
- Malaysia
- Mallinckrodt
- Malvinder Singh
- managed care
- Management
- Mantecorp
- manufacturing
- Manufacturing deals
- manufacuturing suspension
- Map Pharmaceuticals
- Maraviroc
- Marc Hermelin
- Marcia Angell
- Margaret Hamburg
- Marijn Dekkers
- Mark Hermelin
- Mark McDade
- Mark Midei
- Mark Senak
- market access
- marketing approval
- Martha Coakley
- Martindale Pharmaceuticals
- Marty Keller
- Mary McLeod
- Maryland
- Massachusetts
- Matritech
- Matrix Laboratories
- Matrixx Initiatives
- Matrixx Labs
- Matthew Emmens
- Max Baucus
- McKesson
- McNeil
- MD Logistics
- MDS Incsaid
- me-too drugs
- Mead Johnson Nutrition
- Meda
- Medarex
- Medco Health Solutions
- media
- Mediator
- Medicago
- Medicaid
- Medicaid Fraud
- medical device
- Medical device safety
- medical records
- Medical school
- medical science liaisons
- Medicare
- Medicare Part D
- Medicines Company
- MediciNova
- Medicis Pharmaceutical
- MediGene
- MedImmune
- Medley
- Medtronic
- Megace
- melanoma
- Melissa DelBello
- Memory Pharmaceuticals
- meningitis
- Menopause
- Menveo
- Mepha
- Merck
- Merck - Top 10 pharma layoffs of 2011
- Merck Kgaa
- Merck Serono
- Mergers and Acquisitions
- Merial
- Merial Animal Health
- Meridia
- Meridian Life Science
- Mervyn Turner
- meta-analysis
- metabolic drugs
- methadone
- Methodist Hospital Research Institute
- methotrexate
- Metrics
- Mevacor
- Mexico
- MGI Pharma
- MHRA
- Michael Loucks
- Michelex
- Michigan
- Microbix Biosystems
- Microscan
- Middle East
- Middlebrook Pharma
- Mike Leavitt
- Miles White
- Millennium
- Minnesota
- mipomersen
- Mirapex
- Mircera
- Misoprostol
- Mitsubishi
- Mitsubishi Tanabe
- MJ Biopharm
- mobile marketing
- Momenta Pharmaceuticals
- monopoly
- MonoSol Rx
- Montana
- Montreal
- Moody's
- Motrin
- Mount Sinai School of Medicine
- Moxatag
- Mozobil
- MRSA
- MS drugs
- MSD Pharmaceuticals
- MSD Wellcome Trust Hilleman Laboratories
- Multaq
- multiple sclerosis
- myeloid leukemia
- myeloma
- Myfortic
- Mylan
- Mylotarg
- Myobloc
- Myozyme
- Namenda
- Nasacort
- Nastech Pharmaceuticals
- Natco Pharma
- National Alliance on Mental Illness
- natrecor
- Nature Medicine
- Neil Hunt
- Neil MacAllister
- Nektar Therapeutics
- Nembutal
- Neo Quimica
- Nepentes
- Nephron Pharmaceuticals
- Nestle
- Neupogen
- NeuralStem
- Neurontin
- Nevada
- New England Journal of Medicine
- New Jersey
- New Jersey Supreme Court
- New York
- New Zealand
- Newron
- Nexavar
- Nexium
- Nexmed
- NextPharma Technologies
- NHS
- niacin
- Niaspan
- NICE
- Nichi-Iko Pharmaceutical
- Nicholas Valeriani
- Nigeria
- NIH
- NM100060
- Noblis
- non-Hodgkin's lymphoma
- North American Spine Society
- North Carolina
- Norvasc
- Norvir
- Novartis
- Novartis - Top 10 pharma layoffs of 2011
- Novartis India
- Novasep
- NovaSterilis
- Novavax
- Novo Nordisk
- NovoSeven
- Nucynta ER
- Nuedexta
- Nuvigil
- Nycomed
- Nycomed US
- Obagi Medical
- Obama Administration
- obesity
- OctoPlus
- off-label marketing
- off-label use
- Oklahoma
- Olympia Snowe
- Omacor
- Omnia Biologics
- Omnicare
- Omrix Biopharmaceuticals
- Onbrez
- Oncologists
- Oncology drugs
- OneOncology
- Onglyza
- online marketing
- online pharmacies
- Onyx Pharmaceuticals
- operations suspension
- Optimer Pharmaceuticals
- Oracle
- Orchid Chemicals
- Orencia
- Organon Biosciences
- Oriel Therapeutics
- origin labeling
- Orion
- oritavancin
- orlistat
- orphan products
- Ortho Evra
- Oscient Pharmaceuticals
- OSI Pharmaceuticals
- osteoporosis
- OTC
- Otsuka Pharmaceutical
- outcomes
- Outsourcing deals
- ovarian cancer
- Ovation Pharmaceuticals
- overdose
- oversight
- overtime pay
- OxyContin
- Pacira Pharmaceuticals
- pain
- Pain drugs
- Painkiller patch
- Pakistan
- Paladin
- paliperidone palmitate
- Pall Corporation
- Palo Alto
- pancreatic cancer
- pancuronium
- Pandemic Flu
- Pandemrix
- Pantarhei
- Par Pharmaceuticals
- Para Pharmaceuticals
- Parabolic Drugs
- parallel exporting
- Paras Pharmaceuticals
- Park Doctrine
- Parkinson's
- PARP inhibitors
- Pascal Soriot
- Patent
- patent application
- patent expirations
- Patent infringement
- Patent Lawsuits
- patent rules
- patents
- Patheon
- Patient Assistance Programs
- Patient recruitment
- Patient Rights
- Patrick Soon-Shiong
- Paul Bisaro
- Paulo Costa
- Paxil
- pay for delay deals
- Pay-for-performance
- Payments
- PBM
- PBS Biotech
- PDL BioPharma
- PDL241
- PDUFA
- pediatric use
- Pegasys
- Pegintron
- Penn Pharma
- Pepcid Complete
- Perdue Pharma
- PerkinElmer
- Perrigo
- Personalized medicine
- Peru
- Peter Kellogg
- Peter Libby
- Peter Rost
- pets
- Pfizer
- Pfizer - Top 10 pharma layoffs of 2011
- Pfizer Animal Health
- Pharma blockbuster
- Pharma buyout
- Pharma CEO
- Pharma CEO pay
- Pharma CEO salary
- Pharma deals
- pharma earnings
- pharma exec severance pay
- pharma gifts
- Pharma growth
- Pharma investing
- Pharma IPO
- pharma jobs
- Pharma outsourcing
- Pharma Q2 2010 Earnings
- Pharma sales reps
- Pharma Stocks
- Pharma taxes
- pharma websites
- pharma women
- pharma-patient interaction
- pharmaceutical advertising
- pharmaceutical advertising spending
- pharmaceutical hires
- pharmaceutical layoffs
- pharmaceutical sales and marketing
- Pharmaceutics International
- Pharmacia
- pharmacies
- Pharmacovigilance
- pharmacy
- Pharmacyclics
- PharmaSwiss
- Pharmathen
- PharMerica
- Pharmion
- Pharmos
- Phase I
- Philippines
- Phillips
- Phosphocol
- PhRMA
- Physician Payment Sunshine Act
- Physician practices
- pipeline
- Piramal
- Plan B
- Plant closing
- plant expansion
- plastics
- Plavix
- PLoS Medicine
- PML
- PN 400
- Pneumonia Vaccine
- Pneumovax
- PolyMedica
- Polypill
- Positron
- Post Office
- post-approval marketing
- post-marketing
- potassium iodide
- Potiga
- Pozen
- PPD
- PPF
- PPIs
- Pprs
- Pradaxa
- Prandin
- prasugrel
- Pravachol
- preemption
- PregLem
- Premarin
- Premier Research
- Prempro
- Prepandrix
- prescribing data
- prescription drug sales
- Prestige Brands
- Prestwick Pharmaceutical
- Prevacid
- Prevacid 24HR
- Prevenar
- Prevnar
- Prevnar-13
- Prexige
- Prezista
- price fixing
- Prilosec
- Prism
- Pristiq
- privacy
- ProAmatine
- Procrit
- Procter & Gamble
- Product Liability Cases
- product recall
- profits
- Prograf
- Prolensa
- Prolia
- Prolong Pharmaceuticals
- promethazine
- Pronova BioPharma
- propofol
- propoxyphene
- proprietary information
- Proscar
- Prostate Cancer
- prostate drug
- Protek
- Protez
- Protonix
- provenge
- Provigil
- Prozac
- Pseudophedrine
- psychiatrists
- PTSD
- Public Citizen
- Public Health Service Act
- public opinion
- public trust
- Puerto Rico
- Pulmicort
- Purdue
- Q3 Earnings
- QAS
- Qualitest Pharmaceuticals
- quality
- Questcor
- Quintiles
- R&D
- R&D spending
- Ralph Neas
- Ranbaxy
- Rapamune
- Raptiva
- Rare Disease Therapeutics
- rare diseases
- Rasilez
- Ratiopharm
- Razadyne
- RealAge
- Rebif
- Rebig
- Recession
- Reckitt Benckiser
- Reclast
- Regeneron
- RegeneRx
- Reglan
- Regulators
- reimbursement
- reimportation
- Relenza
- Reliable Biopharmaceutical
- Reloxin
- Remicade
- Renee Kaswan
- Replagal
- Repligen
- Republicans
- Requip
- Research Triangle Park
- reselling
- Restalyne
- Restasis
- Restless Leg Syndrome
- restructuring
- Restylane
- Retavase
- Revatio
- Revlimid
- Reyataz
- Rezulin
- rheumatoid arthritis
- Rhonda Greenapple
- Richard Blumenthal
- Richard Clark
- Richard Peto
- Rick Perry
- Rigel Pharmaceuticals
- Risperdal
- Ritalin
- Rituxan
- Robert Armitage
- Robert Berolini
- Robert Bradway
- Robert Coury
- Robert Goldberg
- Robert Jarvik
- Robert Parkinson
- Robert Wessman
- Roche
- rofecoxib
- Rolaids
- Rolenium
- Ron Wyden
- Rotarix
- RotaTeq
- Rottapharm Madaus
- Roxane Laboratories
- RU-486
- Rudy Giuliani
- Rumor
- Russia
- SAFC
- safe
- Sagent Holdings
- Salix Pharmaceuticals
- Sam Waksal
- Samsung Electronics
- Sandoz
- Sandra E. Poole
- Sanjay Gupta
- Sanofi
- Sanofi - Top 10 pharma layoffs of 2011
- Sanofi Pasteur
- Sanofi-Aventis
- Santarus
- Saturn
- Saudi Arabia
- Savient
- Sawai
- Schering-Plough
- Schizophrenia
- Sciele Pharma
- Scientific Laboratories
- Scientific Protein Laboratories
- SCM
- SCM Pharma
- Scotland
- Scott Brown
- Scott Gottleib
- Scott S. Reuben
- SEAS study
- Seasonal flu
- Seattle Genetics
- Securities And Exchange Commission
- security breach
- Seizures
- Seldane
- Selzentry
- Sensipar
- Sentinel
- Sepracor
- Sepsis
- Septic Shock
- Serada
- Serbia
- Serevent
- Serge Weinberg
- Sermo
- Seroquel
- Seroquel XR
- Servier
- settlement
- Severin Schwan
- SGX Pharmaceuticals
- Shanghai Schering-Plough Pharmaceutical
- Shanghai Shering-Plough Pharmaceutical
- Shantha Biotechnics
- shareholder lawsuit
- Shareholders
- Sheri McCoy
- Sherrod Brown
- Shingles
- Shionogi
- Shire
- Shlomo Yanai
- Showa Yakuhin Kako
- Sichuan
- Sidney Taurel
- Sidney Wolfe
- Sigma Pharmaceuticals
- Sigma-Tau
- Sihuan Pharmaceutical
- sildenafil
- Silenor
- Simcere Pharmaceutical
- Simcor
- Simon Dingemans
- Simon Lowth
- Simponi
- Simvastatin
- Singapore
- Singulair
- Sinopharm
- Sinovac
- Skelaxin
- SkyePharma
- Smith & Nephew
- Smoking
- social media
- social networking
- sodium thiopental
- Sol Barrer
- Solaraze
- Soliris
- Solvay
- Somaxon
- Sonus Pharmaceutical
- South Africa
- South Carolina
- South Korea
- Spain
- specialty drugs
- spinoff
- Spirig
- Spiriva
- Sprycel
- SSRI
- St. Jude Medical
- Stada Arzneimittel
- Stalevo
- Standard and Poor's
- Stanford
- staph
- Statins
- Stefan Oschmann
- Stelara
- Stent
- Stephanie Wells
- Stephen Spielberg
- Steven Burrill
- Steven Glason
- Steven Nissen
- Stevens-Johnson syndrome
- Stiefel Laboratories
- Stimulants
- Stock
- stock buyback
- stockpiling
- Stocrin
- strategic options
- strategy
- Strativa
- Strattera
- Strides Arcolab
- strike
- Study 15
- Stupak
- subpoena
- subsidies
- sugammadex
- Suicide Risk
- Sun Pharmaceuticals
- Sunovion Pharmaceuticals
- Superbugs
- supply chain
- Supreme Court
- SureScripts-RxHub
- Surgeon General
- Susan Desmond-Hellmann
- sustainability
- Sutent
- Sweden
- swine flu
- Switzerland
- Symbicort
- Synflorix
- Synthes
- tadalafil
- Taisho Pharmaceutical
- Taisho Pharmaceuticals
- Taiyo
- Takeda Pharmaceutical
- Takeover
- talent
- Tamiflu
- taranabant
- Tarceva
- Targacept Inc
- Targanta Therapeutics
- Taro Pharmaceuticals
- Tasigna
- Taxotere
- Taxus
- TC-5214
- Teaching Hospital
- Ted Kennedy
- Teikoku
- Tekturna
- tender offer
- Tenofovir
- tetrabenazine
- Teva Pharmaceutical
- Teva Pharmaceutical Industries - Top 10 pharma layoffs of 2011
- Texas
- Texas Medication Algorithm Project
- Thailand
- thalidomide
- Theophylline
- therapeutic goods administration
- Theravance
- Thermo Fisher Scientific
- thimerosal
- Thomas Hofstaetter
- Thomas Lonngren
- Thomas Zdeblick
- Threshold Pharmaceuticals
- tibolone
- Tibotec
- Tim Anderson
- Tim Garnett
- Tnf Blocker
- tobacco
- Tom Daschle
- Top 10 pharma layoffs of 2011
- Topamax
- Toprol XL
- torcetrapib
- Torisel
- Torrent Pharmaceuticals
- Trade Associations
- Tradenta
- Trajenta
- Transparency
- Transplant Drugs
- Trasylol
- Treanda
- Tredaptive
- Trends
- Trevor Mundel
- Treximet
- Tricor
- TriLipix
- Triplefin
- Trovan
- Trust Deficit
- Truvada
- TSA
- Tunnell Consulting
- Turkey
- Tygacil
- Tykerb
- Tylenol
- Tysabri
- Tyverb
- U.K. election
- UCB Pharma
- UCLA
- Ulf Wiinberg
- Unapproved drugs
- Unichem
- Unilife
- uninsured
- United Kingdom
- United Medicare
- United States
- United Therapeutics
- UnitedHealth
- Universal Medicare
- universities
- University of Cincinnati
- University of Georgia Research Foundation
- University Of Miami
- University of Pennsylvania
- University Of Pittsburgh Medical Center
- UPS
- URL Pharma
- user fees
- ustekinumab
- Vaccine
- vaccine plant
- vaccine shortage
- vaccines
- Valeant
- Valstar
- Vancocin
- Vanda Pharmaceuticals
- Vaniqua
- Varivax
- Vectibix
- Vectura Group
- Velcade
- Ven-A-Care
- Venezuela
- Ventana
- Verastem
- Verispan
- Vermont
- VeroScience
- Vertex Pharmaceuticals
- Verus
- ViaCell
- Viagra
- Vibativ
- Victoza
- Victrelis
- Vidaza
- Vietnam
- Viibryd
- Viiv Healthcare
- Vioxx
- Viread
- ViroPharma
- Vivitrol
- voluntary recall
- Votrient
- Votubia
- Vpriv
- Vytorin
- Vyvanse
- W. Scott Harkonen
- Wal-Mart
- Walgreen's
- Wall Street
- Warfarin
- Warner Chilcott
- Warner-Lambert
- warning letter
- Warren Buffett
- Watson Pharmaceuticals
- Web marketing
- weight gain
- Wellbutrin XL
- Wellcome Trust
- WellPoint
- Werner Wenning
- West Pharmaceutical Services
- whistleblower
- Wholesale
- wikileaks
- William Burns
- William Ringo
- Wisconsin
- Wockhardt
- Wolters Kluwer Health
- women's health
- World Health Organization
- WTO
- WuXi PharmaTech
- Wyeth
- Wyeth v. Levine
- Xalkori
- Xarelto
- Xcelience
- Xcellerex
- Xeloda
- Xenazine
- Xenical
- Xenoport
- Xgeva
- Xience
- Xifaxan
- Xigris
- Xolair
- Xoma
- Yag-Mag Labs Private Limited
- Yale
- Yasmin
- Yaz
- Yervoy
- Yusuf Hamied
- Zantac
- Zars Pharma
- Zelboraf
- Zelnorm
- Zentiva
- Zetia
- Zhejiang Hisun
- Zhejiang Tianyuan
- Zhuhai United Laboratories
- Zicam
- Zimmer
- Zocor
- Zoloft
- Zometa
- Zonegran
- Zostavax
- Zydus
- Zyflo
- Zyprexa
- Zyprexa Relprevv
- Zyrtec
- Zytiga
- Zyvox
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
